PAVmed (PAVM) Retained Earnings (2015 - 2025)

PAVmed's Retained Earnings history runs 11 years deep, the most recent figure standing at $268.0 million for Q4 2025.

• On a quarterly basis, Retained Earnings rose 205.12% year-over-year to $268.0 million in Q4 2025; TTM through Dec 2025 was $268.0 million, a 205.12% increase from a year earlier, with the FY2025 full-year figure at $268.0 million, up 205.12% from the prior year.
• Retained Earnings climbed to $268.0 million in Q4 2025 per PAVM's latest filing, from -$256.9 million in the prior quarter.
• Across five years, Retained Earnings topped out at $268.0 million in Q4 2025 and bottomed at -$278.5 million in Q3 2023.
• The 5-year median for Retained Earnings is $199.7 million (2022), against an average of $62.8 million.
• Across the five-year window, Retained Earnings soared 324.38% in 2021 and slumped 207.31% in 2024, its largest moves.
• Year by year, Retained Earnings stood at $198.1 million in 2021, then climbed by 9.15% to $216.2 million in 2022, then climbed by 9.9% to $237.6 million in 2023, then slumped by 207.31% to -$255.0 million in 2024, then surged by 205.12% to $268.0 million in 2025.
• Per Business Quant, the three latest PAVM Retained Earnings figures stand at $268.0 million (Q4 2025), -$256.9 million (Q3 2025), and $263.5 million (Q2 2025).